Baxter International Inc. closed 24.01% short of its 52-week high of $44.01, which the company reached on March 8th.
Q4 2024 Management View Interim CEO Brent Shafer highlighted the completion of the Vantive sale as a significant milestone in Baxter's transformation strategy and noted the company's focus on ...
Baxter International Inc. BAX reported fourth-quarter 2024 adjusted earnings per share (EPS) of 58 cents, which beat the Zacks Consensus Estimate of 52 cents by 11.5%. The bottom line declined 10.8% ...
Baxter International Inc. ( NYSE: BAX) Q4 2024 Earnings Conference Call February 20, 2025 8:30 AM ET Clare Trachtman - SVP and Chief IRO Brent Shafer - Chairman, and Interim CEO Heather Knight - COO ...
February 18, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader ... (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an ...
Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...
Baxter International Inc. (NYSE: BAX) has recently announced significant changes to its executive leadership and provided an update on its financial outlook through an 8-K filing with the Securities ...
February 03, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech ... will retire from his executive roles with the company, effective immediately. He will serve in ...
Baxter International Inc. (NYSE:BAX – Get Free Report) has been assigned an average recommendation of “Hold” from the ten brokerages that are covering the stock, MarketBeat.com reports. One equities ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
February 03, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his ...